These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6539512)

  • 1. The behaviour of urokinase and porcine kidney cell plasminogen activator towards some synthetic peptides.
    Walker B; Elmore DT
    Thromb Res; 1984 Apr; 34(2):103-7. PubMed ID: 6539512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of substrates with 7-amino-3-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ.
    Lojda Z
    Acta Histochem; 1996 Apr; 98(2):215-28. PubMed ID: 8739306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
    Morita T; Kato H; Iwanaga S; Takada K; Kimura T
    J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical conjugation of Gly-Pro-Arg-Pro. Tetrapeptide to low molecular weight urokinase.
    Chen XC; Hua ZC; Zhu DX
    Biochem Mol Biol Int; 1996 Jun; 39(3):455-60. PubMed ID: 8828796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of tissue plasminogen activator and urokinase as determined with synthetic chromogenic substrates.
    Matsuo O; Sakai T; Takakura Y; Mihara H
    Jpn J Physiol; 1983; 33(6):1031-7. PubMed ID: 6687071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
    Hua ZC; Chen XC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay method for single-chain urokinase-type plasminogen activator.
    Matsuo O; Ueshima S; Okada K; Fukao H; Ohgaki M; Watanabe R; Arimura H
    Hematol Pathol; 1989; 3(3):137-42. PubMed ID: 2531734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.
    Kirchheimer J; Köller A; Binder BR
    Biochim Biophys Acta; 1984 Feb; 797(2):256-65. PubMed ID: 6199043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
    Thorsen S; Astrup T
    Haemostasis; 1976; 5(5):295-305. PubMed ID: 14058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastase digested urokinase (ED-UK).
    Sumi H; Kosugi T; Toki N; Mihara H
    Experientia; 1985 Dec; 41(12):1546-8. PubMed ID: 3852742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorogenic substrates for sensitive and differential estimation of urokinase and tissue plasminogen activator.
    Nieuwenhuizen W; Wijngaards G; Groeneveld E
    Haemostasis; 1978; 7(2-3):146-9. PubMed ID: 658777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on tissue culture plasminogen activator. II. The detection and assay of urokinase and plasminogen activator from LLC-PK cultures (porcine) by the synthetic substrate Nalpha-benzyloxycarbonyl-glycyl-glycyl-arginyl-4-methoxy-2-napthylamide.
    Huseby RM; Clavin SA; Smith RE; Hull RN; Smithwick EL
    Thromb Res; 1977 May; 10(5):679-87. PubMed ID: 882957
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
    Hijikata A; Okamoto S; Kikumoto R; Tamao Y
    Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
    Finci Z; Nachshon I; Sharoni Y; Mayer M
    Exp Hematol; 1986 May; 14(4):293-7. PubMed ID: 2938980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.